Cargando…
Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
Autores principales: | Arnon, Tal I., Markel, Gal, Bar-Ilan, Ahuva, Hanna, Jacob, Fima, Eyal, Benchetrit, Fabrice, Galili, Ruth, Cerwenka, Adelheid, Benharroch, Daniel, Sion-Vardy, Netta, Porgador, Angel, Mandelboim, Ofer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2637116/ http://dx.doi.org/10.1371/annotation/eaf9794a-9325-4977-952d-51285c3f6c6a |
Ejemplares similares
-
Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2008) -
Correction: Harnessing Soluble NK Cell Killer Receptors for the Generation of Novel Cancer Immune Therapy
por: Arnon, Tal I., et al.
Publicado: (2015) -
CD100 on NK Cells Enhance IFNγ Secretion and Killing of Target Cells Expressing CD72
por: Mizrahi, Sa'ar, et al.
Publicado: (2007) -
NK Cells Under Hypoxia: The Two Faces of Vascularization in Tumor and Pregnancy
por: Garcés-Lázaro, Irene, et al.
Publicado: (2022) -
Targeting Natural Killer Cell Reactivity by Employing Antibody to NKp46: Implications for Type 1 Diabetes
por: Yossef, Rami, et al.
Publicado: (2015)